agilon health (NYSE:AGL) Trading 12.8% Higher – Still a Buy?

agilon health, inc. (NYSE:AGL) rose 12.8% during trading on Wednesday . The company traded as high as $3.46 and last traded at $3.58. Approximately 6,937,005 shares were traded during mid-day trading, an increase of 53% from the average daily volume of 4,530,061 shares. The stock had previously closed at $3.17.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on AGL shares. Macquarie assumed coverage on agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Barclays cut their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research note on Monday, November 11th. Sanford C. Bernstein boosted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Finally, Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and raised their target price for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, agilon health presently has a consensus rating of “Hold” and a consensus price target of $3.95.

agilon health Stock Up 11.5 %

The firm has a 50 day moving average of $3.01 and a two-hundred day moving average of $2.97. The stock has a market capitalization of $1.46 billion, a PE ratio of -3.76 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

Insider Activity

In other agilon health news, Director Karen Mcloughlin purchased 25,000 shares of the stock in a transaction dated Friday, December 13th. The shares were acquired at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director John William Wulf acquired 45,000 shares of the company’s stock in a transaction dated Thursday, December 5th. The shares were acquired at an average cost of $2.18 per share, with a total value of $98,100.00. Following the completion of the purchase, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 77,500 shares of company stock worth $169,600 over the last 90 days. 3.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On agilon health

Several hedge funds have recently bought and sold shares of AGL. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of agilon health by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 797,658 shares of the company’s stock valued at $1,516,000 after acquiring an additional 157,610 shares during the last quarter. Two Sigma Advisers LP boosted its stake in shares of agilon health by 4,393.5% during the 4th quarter. Two Sigma Advisers LP now owns 480,800 shares of the company’s stock worth $914,000 after purchasing an additional 470,100 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of agilon health by 73.7% during the fourth quarter. Two Sigma Investments LP now owns 857,867 shares of the company’s stock worth $1,630,000 after buying an additional 363,855 shares in the last quarter. State of Wyoming grew its holdings in shares of agilon health by 89.3% during the fourth quarter. State of Wyoming now owns 122,504 shares of the company’s stock worth $233,000 after buying an additional 57,802 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new position in shares of agilon health in the fourth quarter valued at approximately $768,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.